<DOC>
	<DOCNO>NCT01665079</DOCNO>
	<brief_summary>The aim study characterize Pharmacokinetic/Pharmacodynamic relationship single bolus dose propofol obese patient extract time peak effect ( t-peak ) estimate model parameter .</brief_summary>
	<brief_title>Propofol Effect-Site Target Controlled Infusion Obese : Characterization Time Profile Bispectral Index Response</brief_title>
	<detailed_description>Target control infusion ( TCI ) technique administer intravenous drug allow rapid achievement maintenance predetermine drug concentration , either plasma ( Cp ) site effect ( Ce ) . To characterize time profile propofol effect additional parameter , equilibration half time plasma effect site ( T1/2keo ) need incorporate pharmacokinetic ( PK ) model .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<criteria>IMC &gt; 35 kg m2 Scheduled laparoscopic bariatric surgery ASA III patient Between 20 60 yr age . Patients allergy study drug Uncontrolled hypertension Heart block great first degree Take drug act central nervous system</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>anaesthetic iv</keyword>
	<keyword>propofol</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamic</keyword>
</DOC>